MONTIPORA Trademark

Trademark Overview

On Monday, September 22, 2025, a trademark application was filed for MONTIPORA with the United States Patent and Trademark Office. The USPTO has given the MONTIPORA trademark a serial number of 99405227. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 22, 2025. This trademark is owned by Grupo Comercializador Enfran, S.A. de C.V.. The MONTIPORA trademark is filed in the Insurance & Financial Services category with the following description:

Capital investment; Financial analysis; Financial research; Investment of funds; Providing financial information; Securities brokerage; Financial advice
montipora

General Information

Serial Number99405227
Word MarkMONTIPORA
Filing DateMonday, September 22, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateMonday, September 22, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesCapital investment; Financial analysis; Financial research; Investment of funds; Providing financial information; Securities brokerage; Financial advice

Classification Information

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateMonday, September 22, 2025
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGrupo Comercializador Enfran, S.A. de C.V.
Party Type10 - Original Applicant
Legal Entity Type85 - NOT AVAILABLE
AddressNew Orleans, LA 70190-0634

Trademark Events

Event DateEvent Description
Monday, September 22, 2025NEW APPLICATION ENTERED
Monday, September 22, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

montipora financial investment securities brokerage advice information funds analysis research capital